Drug recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL)
Presence of particulate matter: a white thread-like structure in the cartridge — Lupin Pharmaceuticals Inc. · Class II · Ongoing · 217,621 pen injectors
The latest headlines across every section, pulled from official and open-access sources.
Presence of particulate matter: a white thread-like structure in the cartridge — Lupin Pharmaceuticals Inc. · Class II · Ongoing · 217,621 pen injectors
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit — Zydus Pharmaceuticals (USA) Inc · Class II · Ongoing · 23,880 bottles
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. — Amerisource Health Services LLC · Class III · Ongoing · 225,000 tablets
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. — Golden State Medical Supply Inc. · Class III · Ongoing · 8,526 bottles
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. — Golden State Medical Supply Inc. · Class III · Ongoing · 1,620 bottles
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus. — Wisconsin Pharmacal Company · Class I · Ongoing · 690 tubes
Lack of Assurance of Sterility — UCB Biosciences Inc. · Class II · Ongoing · 141,708 cartons
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. — Amerisource Health Services LLC · Class III · Ongoing · 63,500 tablets
Defective Container; packets were found to be either empty or partially full. — ANI Pharmaceuticals, Inc. · Class II · Ongoing · 3964 Cartons
Failed Impurities/Degradation Specifications — Sagent Pharmaceuticals · Class III · Ongoing · Lot 656412: 6,200 vials. Lot 659646: 3,328 vials
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. — Lannett Company Inc. · Class III · Ongoing · 44865 bottles
Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling. — Haleon US Holdings LLC · Class II · Ongoing · 285,330 blister cards
Presence of a Foreign Substance; black particles observed in liquid — Safecor Health, LLC · Class II · Ongoing · 520 syringes
Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss. — Becton, Dickinson and Company · Class II · Ongoing
The deaeration hose in X-ray tube cooling units type CU3101, manufactured between February 2016 and May 2020, may degrade over time, potentially resulting in oil leakage. Oil leakage may affect the cooling performance of the X-ray tube. When the oil flow drops below a certain threshold, the system automatically switches to low-dose fluoroscopy and display… — PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss. — Becton, Dickinson and Company · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Certain lots of product have the potential for a sterile barrier breach. — Medtronic Perfusion Systems · Class II · Ongoing
Potential safety issue with Philips Azurion systems, where longitudinal and transverse table movements may be impacted due to mechanical wear of the Float Tabletop control on the control module. — PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. · Class II · Ongoing
Intervertebral body fusion system straight inserter failed to properly attach to affected cages, which may result in an inability to securely engage the implant with the inserter, which could lead to procedural delay and/or the need to select an alternative implant. — Novapproach Spine, LLC · Class II · Ongoing